Rangwala Reshma
EVP & Chief Medical Officer
Rangwala Reshma has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 15, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8K
reported sales (SEC code S)
Companies
1
in the rolling window